The Effect of Everolimus Initiation and Calcineurin Inhibitor Reduction on Allograft Vasculopathy in Maintenance Heart Transplant Recipients: Results of the NOCTET Trial After 5 Years

被引:1
|
作者
Arora, S. [1 ]
Karason, K. [2 ]
Eisjaer, H. [3 ]
Botker, H. [3 ]
Gustafsson, F. [4 ]
Saunamaki, K. [4 ]
Radegran, G. [5 ]
Gude, E. [1 ]
Aaberge, L. [1 ]
Ueland, T. [6 ]
Aukrust, P. [6 ]
Solbu, D. [7 ]
Gullestad, L. [1 ]
机构
[1] Univ Oslo, Rikshosp, Oslo Univ Hosp, Cardiol, N-0027 Oslo, Norway
[2] Sahlgrens Univ Hosp, Cardiol, Gothenburg, Sweden
[3] Skeiby Univ Hosp, Cardiol, Aarhus, Denmark
[4] Rigshosp, Cardiol, DK-2100 Copenhagen, Djibouti, Denmark
[5] Lund Hosp, Cardiol, Lund, Sweden
[6] Univ Oslo, Rikshosp, Oslo Univ Hosp, Res Inst Internal Med, N-0027 Oslo, Norway
[7] Novartis Norge, Oslo, Norway
来源
关键词
D O I
10.1016/j.healun.2015.01.077
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
66
引用
收藏
页码:S32 / S32
页数:1
相关论文
共 50 条
  • [1] The Effect of Everolimus Initiation and Early Calcineurin Inhibitor Withdrawal on Allograft Vasculopathy in De-Novo Heart Transplant Recipients: Results of the Schedule Trial after 6 Years
    Arora, S.
    Karason, K.
    Gustafsson, F.
    Eiskjaer, H.
    Radegran, G.
    Aaberge, L.
    Gude, E.
    Solbu, D.
    Dellgren, G.
    Andreassen, A. K.
    Gullestad, L.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S36 - S36
  • [2] The Effect of Everolimus Initiation and Early Calcineurin Inhibitor Withdrawal on Allograft Vasculopathy in De-Novo Heart Transplant: Recipients: Results of the SCHEDULE Trial After 36 Months
    Arora, S.
    Solberg, O.
    Karason, K.
    Andersson, B.
    Gustafsson, F.
    Eiskjaer, H.
    Radegran, G.
    Gude, E.
    Ueland, T.
    Aukrust, P.
    Solbu, D.
    Dellgren, G.
    Andreassen, A.
    Gullestad, L.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (04): : S85 - S85
  • [3] Effect of Everolimus Introduction and Calcineurin Inhibitor Reduction on Graft Vasculopathy in Heart Transplant Recipients
    Arora, S.
    Wennerblom, B.
    Rundqvist, B.
    Eiskjaer, H.
    Botker, H. E.
    Mortensen, S-A
    Saunameki, K.
    Ekmehag, B.
    Jansson, K.
    Simonsen, S.
    Gude, E.
    Endresen, K.
    Solbu, D.
    Gullestad, L.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (02): : S50 - S50
  • [4] EFFECT OF EVEROLIMUS INTRODUCTION AND CALCINEURIN INHIBITOR REDUCTION ON GRAFT VASCULOPATHY IN HEART TRANSPLANT RECIPIENTS
    Arora, Satish
    Wennerblom, Bertil
    Rundqvist, Bengt
    Eiskjaer, Hans
    Botker, Hans
    Mortensen, Svend Aage
    Saunameki, Kari
    Ekmehag, Bjorn
    Janssson, Kjell
    Simonsen, Svein
    Gude, Einar
    Endresen, Knut
    Solbu, Dag
    Gullestad, Lars
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [5] Everolimus Initiation With Calcineurin Inhibitor Withdrawal Reduces Allograft Vasculopathy in De-Novo Heart Transplant Recipients
    Arora, S.
    Andersson, B.
    Gustafsson, E.
    Eiskjaer, H.
    Radegran, G.
    Aaberge, L.
    Erikstad, I.
    Gude, E.
    Ueland, T.
    Aukrust, P.
    Solbu, D.
    Dellgren, G.
    Andreassen, A.
    Gullestad, L.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (04): : S154 - S154
  • [6] Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Heart Transplant Recipients Three-Year Results of a Scandinavian Randomized Trial
    Arora, Satish
    Andreassen, Arne K.
    Karason, Kristjan
    Gustafsson, Finn
    Eiskjaer, Hans
    Botker, Hans Erik
    Radegran, Goran
    Gude, Einar
    Ioanes, Dan
    Solbu, Dag
    Dellgren, Goran
    Ueland, Thor
    Aukrust, Pal
    Gullestad, Lars
    [J]. CIRCULATION-HEART FAILURE, 2018, 11 (09) : e004050
  • [7] Everolimus Initiation and Early Calcineurin Inhibitor Withdrawal in Heart Transplant Recipients: A Randomized Trial
    Andreassen, A. K.
    Andersson, B.
    Gustafsson, F.
    Eiskjaer, H.
    Rdegran, G.
    Gude, E.
    Jansson, K.
    Solbu, D.
    Sigurdardottir, V.
    Arora, S.
    Dellgren, G.
    Gullestad, L.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 (08) : 1828 - 1838
  • [8] The Effect of Everolimus Initiation and Early Calcineurin Inhibitor Withdrawal on Allograft Vasculopathy Assessed by Virtual Histology: Results of the SCHEDULE Trial
    Arora, S.
    Solberg, O.
    Gustafsson, F.
    Karason, K.
    Eiskjaer, H.
    Botker, H. E.
    Radegran, G.
    Dellgren, G.
    Ioanes, D.
    Gude, E.
    Solbu, D.
    Andreassen, A. K.
    Gullestad, L.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (04): : S16 - S17
  • [9] Everolimus initiation with early calcineurin inhibitor withdrawal reduced allograft vaculopathy in de-novo heart transplant recipients: results of the SCHEDULE trial
    Arora, S.
    Andersson, B.
    Gustafsson, F.
    Eiskjaer, H.
    Raadegran, G.
    Aaberge, L.
    Erikstad, I.
    Gude, E.
    Solbu, D.
    Gullestad, L.
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 : 179 - 180
  • [10] The Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Recipients: One-Year Results of a Scandinavian Randomized Trial
    Arora, S.
    Andreassen, A. K.
    Andersson, B.
    Gustafsson, F.
    Eiskjaer, H.
    Botker, H. E.
    Radegran, G.
    Gude, E.
    Ioanes, D.
    Solbu, D.
    Sigurdardottir, V.
    Dellgren, G.
    Erikstad, I.
    Solberg, O. G.
    Ueland, T.
    Aukrust, P.
    Gullestad, L.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15 (07) : 1967 - 1975